Orna Therapeutics

Orna Therapeutics develops innovative methods and drugs in the field of RNA therapeutics. The firm plans to use its products to help treat various kinds of diseases.

NewsHeat chart

  • Week
  • Month
  • Year
  • Media news
  • Corp news
Click to unlock the chart

The data in the chart above is based on data derived from our proprietary XP calculation model and may be changed, adjusted and updated without prior notice

Company Valuation

  • Valuation
  • Share Price
  • Cumulative Funding

The data in the tables and charts is based on data from public sources and although we make every effort to compile the data, it may not coincide with the actual data of the issuer.

Funding Round
Funding Amount
Post-Money Valuation
Share Price
Series B16 Aug, 2022
***
***
***
Series A24 Feb, 2021
***
***
***
Seed1 Jan, 2020
***
***
***

*** - To view the data, please log into your account or create a new one.

News related to Orna Therapeutics3

Filter by
Sort by
Orna Therapeutics
Apr 11, 2024Show on chart

Orna Therapeutics Appoints Frank Neumann, M.D., Ph.D., as Chief ...

PRNewswire/ -- Orna Therapeutics, a biotechnology company dedicated to designing and delivering a new class of fully engineered circular RNA therapeutics...

https://www.prnewswire.com/news-releases/orna-therapeutics-appoints-frank-neumann-md-phd-as-chief-medical-officer-302113457.html
Orna Therapeutics
Jan 5, 2023Show on chart

Simnova and Orna Therapeutics Collaborate to Advance Orna's ...

Simnova and Orna Therapeutics Collaborate to Advance Orna's Next Generation Circular RNA Technology in China ...

https://www.prnewswire.com/news-releases/simnova-and-orna-therapeutics-collaborate-to-advance-ornas-next-generation-circular-rna-technology-in-china-301714094.html
Orna Therapeutics
Aug 16, 2022Show on chart

BioImpact Capital Announces a Multi-Billion Dollar Landmark Transaction in Vaccines and Cancer

BioImpact Capital, an affiliate of MPM Capital ("MPM"), announced today that Orna Therapeutics ...

https://www.benzinga.com/pressreleases/22/08/b28512887/bioimpact-capital-announces-a-multi-billion-dollar-landmark-transaction-in-vaccines-and-cancer

Investors2

MerckMerck
MPM CapitalMPM Capital

Orna Therapeutics Twitter